Takeda Pharmaceutical Co, Japan’s largest drugmaker, agreed to buy Millennium Pharmaceuticals Inc for US$8.8 billion, gaining a blood-cancer medicine before the patent on its best-selling Actos diabetes pill expires in 2011.
Stockholders of Cambridge, Massachusetts-based Millennium will receive US$25 a share in cash, 53 percent more than yesterday’s closing price, the two companies said in a statement today. It is Japan’s largest drug acquisition.
Millennium’s cancer treatment Velcade widens the product pipeline Osaka-based Takeda is developing to buffer sales once Actos faces generic competition. Rival Eisai Co agreed in December to buy US drugmaker MGI Pharma Inc for US$3.9 billion to gain more cancer medicines.
“This deal will boost Takeda’s drug-development flow,” said Mitsuo Ohmi, a Tokyo-based analyst at Japan Advisory LLC. “Millennium is a leader in genome medicine, with some promising drugs in early development.”
The US company generated US$265 million in sales last year from Velcade, which is sold in more than 80 countries. Overall revenue climbed 8 percent to US$528 million. Millennium earned US$14.9 million in net income, its first profit since 1998, according to data compiled by Bloomberg.
Takeda fell 2.5 percent to ¥5,410 on the Tokyo Stock Exchange before the announcement. Millennium gained 41 percent in the past year. The takeover premium is more than double the 23 percent Tokyo-based Eisai paid to acquire MGI Pharma.
Japanese drugmakers are expanding outside the world’s second-largest drug market because domestic growth is hampered by a government policy to cut prescription-medicine prices every two years.
“Millennium has strong discovery, development and commercial capabilities led by a well-established management team,” Takeda president Yasuchika Hasegawa said in the statement. “Takeda is committed to becoming a global leader in oncology.”
WAITING GAME: The US has so far only offered a ‘best rate tariff,’ which officials assume is about 15 percent, the same as Japan, a person familiar with the matter said Taiwan and the US have completed “technical consultations” regarding tariffs and a finalized rate is expected to be released soon, Executive Yuan spokeswoman Michelle Lee (李慧芝) told a news conference yesterday, as a 90-day pause on US President Donald Trump’s “reciprocal” tariffs is set to expire today. The two countries have reached a “certain degree of consensus” on issues such as tariffs, nontariff trade barriers, trade facilitation, supply chain resilience and economic security, Lee said. They also discussed opportunities for cooperation, investment and procurement, she said. A joint statement is still being negotiated and would be released once the US government has made
NEW GEAR: On top of the new Tien Kung IV air defense missiles, the military is expected to place orders for a new combat vehicle next year for delivery in 2028 Mass production of Tien Kung IV (Sky Bow IV) missiles is expected to start next year, with plans to order 122 pods, the Ministry of National Defense’s (MND) latest list of regulated military material showed. The document said that the armed forces would obtain 46 pods of the air defense missiles next year and 76 pods the year after that. The Tien Kung IV is designed to intercept cruise missiles and ballistic missiles to an altitude of 70km, compared with the 60km maximum altitude achieved by the Missile Segment Enhancement variant of PAC-3 systems. A defense source said yesterday that the number of
‘CRUDE’: The potential countermeasure is in response to South Africa renaming Taiwan’s representative offices and the insistence that it move out of Pretoria Taiwan is considering banning exports of semiconductors to South Africa after the latter unilaterally downgraded and changed the names of Taiwan’s two representative offices, the Ministry of Foreign Affairs (MOFA) said yesterday. On Monday last week, the South African Department of International Relations and Cooperation unilaterally released a statement saying that, as of April 1, the Taipei Liaison Offices in Pretoria and Cape Town had been renamed the “Taipei Commercial Office in Johannesburg” and the “Taipei Commercial Office in Cape Town.” Citing UN General Assembly Resolution 2758, it said that South Africa “recognizes the People’s Republic of China (PRC) as the sole
Taiwanese exports to the US are to be subject to a 20 percent tariff starting on Thursday next week, according to an executive order signed by US President Donald Trump yesterday. The 20 percent levy was the same as the tariffs imposed on Vietnam, Sri Lanka and Bangladesh by Trump. It was higher than the tariffs imposed on Japan, South Korea and the EU (15 percent), as well as those on the Philippines (19 percent). A Taiwan official with knowledge of the matter said it is a "phased" tariff rate, and negotiations would continue. "Once negotiations conclude, Taiwan will obtain a better
RSS